4.8 Article

Interleukin-11 signaling promotes cellular reprogramming and limits fibrotic scarring during tissue regeneration

Journal

SCIENCE ADVANCES
Volume 7, Issue 37, Pages -

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.abg6497

Keywords

-

Funding

  1. DFG [RE3148/1-1, CRC1213]
  2. NIH [HL54737]
  3. Packard Foundation
  4. Leducq Foundation
  5. Max Planck Society

Ask authors/readers for more resources

Il-11/Stat3 signaling in zebrafish has a dual function of limiting fibrosis and promoting tissue regeneration. The research shows that Il-11 signaling can drive cellular reprogramming and antagonize scar formation in adult mammals. This reveals novel targets for regenerative therapies.
Damage-induced fibrotic scarring limits tissue regeneration in mammals and is a leading cause of morbidity. In contrast, species like zebrafish can regenerate damaged tissues without excessive fibrosis. However, whether specific signaling pathways can both limit fibrosis and promote regeneration is unclear. Here, we show that interleukin-11 (Il-11)/Stat3 signaling has such a dual function. Zebrafish lacking Il-11 receptor function display severely compromised heart, fin, and scale regeneration. Deep phenotyping and transcriptional analysis of adult hearts and fins show that Il-11 signaling drives cellular reprogramming to orchestrate global and tissue-specific regenerative programs and broadly antagonizes hallmarks of adult mammalian scarring. Mechanistically, our data indicate that IL-11 signaling in endothelial cells antagonizes profibrotic transforming growth factor-beta signaling and endothelial-to-mesenchymal transition, limiting scarring and promoting cardiomyocyte repopulation, after injury. Overall, our findings position damage-induced Il-11/Stat3 signaling in a key role limiting fibrosis and promoting regeneration, revealing novel targets for regenerative therapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available